Post-Orgasmic Illness Syndrome Successfully Treated with Omalizumab: A Case Report.

IF 2.1 3区心理学 Q2 FAMILY STUDIES

Journal of Sex & Marital Therapy Pub Date : 2024-01-01 Epub Date: 2023-12-21 DOI:10.1080/0092623X.2023.2295256

Andrew McLean-Tooke, Elizabeth Klinken

引用次数: 0

Abstract

Post-orgasmic illness syndrome (POIS) is a rare disorder associated with a debilitating symptoms post-ejaculation associated with significant impairment in quality of life. The mechanism of the disease is unclear, but hypersensitivity to semen and/or seminal fluid has been postulated. We present a case of POIS successfully treated with omalizumab suggesting a possible role for this therapy in POIS treatment and management.

查看原文本刊更多论文

用奥马珠单抗成功治疗 "痉病后综合征"：病例报告。

性高潮后疾病综合征（POIS）是一种罕见的疾病，患者在射精后会出现衰弱症状，严重影响生活质量。该病的发病机制尚不清楚，但有人推测是对精液和/或精液过敏。我们介绍了一例使用奥马珠单抗成功治疗的 POIS 病例，这表明奥马珠单抗疗法在 POIS 的治疗和管理中可能发挥作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Sex & Marital Therapy Multiple-

CiteScore

4.70

自引率

12.00%

发文量

107

期刊介绍： The Journal of Sex and Marital Therapy is one of the top independent journals in the field. Under the prestigious leadership of R. Taylor Seagraves, M.D. - one of the world" foremost experts in sex and marital therapy -- JSMT is an active and contemporary forum reflecting the most viable developments emanating from the U.S. and abroad. JSMT continues to break new ground with innovative research and clinical writing, and the editor is committed to showcasing the most far-reaching traditional and contemporary thinking from all sources. You will read about therapeutic techniques, outcome, special clinical and medical problems, and the theoretical parameters of sexual functioning, and marital relationships.